• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期脑室抗生素治疗可改善神经重症患者多重耐药菌医院获得性细菌性脑膜炎和脑室炎的住院死亡率。

Early Intraventricular Antibiotic Therapy Improved In-Hospital-Mortality in Neurocritical Patients with Multidrug-Resistant Bacterial Nosocomial Meningitis and Ventriculitis.

机构信息

Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Middle Wulumuqi Road 12#, Jing'an District, Shanghai, 200040, China.

Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.

出版信息

Neurocrit Care. 2024 Apr;40(2):612-620. doi: 10.1007/s12028-023-01781-7. Epub 2023 Jul 27.

DOI:10.1007/s12028-023-01781-7
PMID:37498458
Abstract

BACKGROUND

Hospital-acquired multidrug-resistant (MDR) bacterial meningitis and/or ventriculitis (MEN) is a severe condition associated with high mortality. The risk factors related to in-hospital mortality of patients with MDR bacterial MEN are unknown. We aimed to examine factors related to in-hospital mortality and evaluate their prognostic value in patients with MDR bacterial MEN treated in the neurointensive care unit.

METHODS

This was a single-center retrospective cohort study of critically ill neurosurgical patients with MDR bacterial MEN admitted to our hospital between January 2003 and March 2021. Data on demographics, admission variables, treatment, time to start of intraventricular (IVT) therapy, and in-hospital mortality were analyzed. Both univariate and multivariable analyses were performed to identify determinants of in-hospital mortality.

RESULTS

All 142 included patients received systemic antibiotic therapy, and 102 of them received concomitant IVT treatment. The median time to start of IVT treatment was 2 days (interquartile range 1-5 days). The time to start of IVT treatment had an effect on in-hospital mortality (hazard ratio 1.17; 95% confidence interval 1.02-1.34; adjusted p = 0.030). The cutoff time to initiate IVT treatment was identified at 3 days: patients treated within 3 days had a higher cerebrospinal fluid (CSF) sterilization rate (81.5%) and a shorter median time to CSF sterilization (7 days) compared with patients who received delayed IVT treatment (> 3 days) (48.6% and 11.5 days, respectively) and those who received intravenous antibiotics alone (42.5% and 10 days, respectively).

CONCLUSIONS

Early IVT antibiotics were associated with superior outcomes in terms of the in-hospital mortality rate, time to CSF sterilization, and CSF sterilization rate compared with delayed IVT antibiotics and intravenous antibiotics alone.

摘要

背景

医院获得性多重耐药(MDR)细菌脑膜炎和/或脑室炎(MEN)是一种死亡率高的严重疾病。与 MDR 细菌 MEN 患者住院死亡率相关的危险因素尚不清楚。我们旨在研究与 MDR 细菌 MEN 患者住院死亡率相关的因素,并评估它们在神经重症监护病房接受治疗的患者中的预后价值。

方法

这是一项单中心回顾性队列研究,纳入了 2003 年 1 月至 2021 年 3 月期间我院收治的患有 MDR 细菌 MEN 的危重病神经外科患者。分析了人口统计学、入院变量、治疗、开始脑室(IVT)治疗的时间以及住院死亡率的数据。进行了单变量和多变量分析,以确定住院死亡率的决定因素。

结果

所有 142 例纳入的患者均接受了全身抗生素治疗,其中 102 例患者接受了同时的 IVT 治疗。开始 IVT 治疗的中位时间为 2 天(四分位间距 1-5 天)。开始 IVT 治疗的时间对住院死亡率有影响(风险比 1.17;95%置信区间 1.02-1.34;调整后 p=0.030)。确定开始 IVT 治疗的时间截点为 3 天:在 3 天内接受治疗的患者具有更高的脑脊液(CSF)杀菌率(81.5%)和更短的 CSF 杀菌中位时间(7 天),与接受延迟 IVT 治疗(>3 天)的患者(分别为 48.6%和 11.5 天)和单独接受静脉内抗生素治疗的患者(分别为 42.5%和 10 天)相比。

结论

与延迟 IVT 抗生素和单独静脉内抗生素相比,早期 IVT 抗生素在住院死亡率、CSF 杀菌时间和 CSF 杀菌率方面具有更好的疗效。

相似文献

1
Early Intraventricular Antibiotic Therapy Improved In-Hospital-Mortality in Neurocritical Patients with Multidrug-Resistant Bacterial Nosocomial Meningitis and Ventriculitis.早期脑室抗生素治疗可改善神经重症患者多重耐药菌医院获得性细菌性脑膜炎和脑室炎的住院死亡率。
Neurocrit Care. 2024 Apr;40(2):612-620. doi: 10.1007/s12028-023-01781-7. Epub 2023 Jul 27.
2
Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and/or ventriculitis in a serious clinical state.在严重临床状态下的神经外科术后脑膜炎和/或脑室炎患者中,进行脑室和腰椎鞘内给予抗生素。
J Neurosurg. 2013 Dec;119(6):1596-602. doi: 10.3171/2013.6.JNS122126. Epub 2013 Aug 16.
3
Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study.神经外科术后革兰氏阴性杆菌性脑膜炎或脑室炎的脑室抗菌治疗:一项基于医院的回顾性研究。
J Microbiol Immunol Infect. 2014 Jun;47(3):204-10. doi: 10.1016/j.jmii.2012.08.028. Epub 2012 Nov 30.
4
Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii.碳青霉烯类耐药鲍曼不动杆菌引起的神经外科术后脑膜炎和脑室炎的鞘内或脑室给予黏菌素辅助治疗的结果。
Int J Antimicrob Agents. 2018 Apr;51(4):646-650. doi: 10.1016/j.ijantimicag.2017.12.002. Epub 2017 Dec 11.
5
Current Practices of Intraventricular Antibiotic Therapy in the Treatment of Meningitis and Ventriculitis: Results from a Multicenter Retrospective Cohort Study.脑室抗生素治疗在脑膜炎和脑室炎治疗中的应用现状:一项多中心回顾性队列研究的结果。
Neurocrit Care. 2019 Jun;30(3):609-616. doi: 10.1007/s12028-018-0647-0.
6
Empirical Combination Antibiotic Therapy Improves the Outcome of Nosocomial Meningitis or Ventriculitis in Neuro-Critical Care Unit Patients.经验性联合抗生素治疗可改善神经重症监护病房患者医院获得性脑膜炎或脑室炎的预后。
Surg Infect (Larchmt). 2016 Aug;17(4):465-72. doi: 10.1089/sur.2015.060. Epub 2016 Apr 22.
7
Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review.脑室和鞘内注射黏菌素作为治疗多重耐药和广泛耐药鲍曼不动杆菌脑室炎和脑膜炎的最后治疗手段:文献复习。
Int J Antimicrob Agents. 2013 Jun;41(6):499-508. doi: 10.1016/j.ijantimicag.2013.02.006. Epub 2013 Mar 16.
8
Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin.静脉注射或脑室内注射加静脉注射多粘菌素治疗脑膜炎/脑室炎的疗效
Acta Neurochir (Wien). 2016 Mar;158(3):603-10; discussion 610. doi: 10.1007/s00701-016-2702-y. Epub 2016 Jan 23.
9
Intraventricular antibiotics for bacterial meningitis in neonates.新生儿细菌性脑膜炎的脑室内抗生素治疗
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD004496. doi: 10.1002/14651858.CD004496.pub3.
10
The Role of Intraventricular Antibiotics in the Treatment of Nosocomial Ventriculitis/Meningitis from Gram-Negative Pathogens: A Systematic Review and Meta-Analysis.脑室内使用抗生素在治疗革兰氏阴性病原菌引起的医院获得性脑室炎/脑膜炎中的作用:一项系统评价和荟萃分析
World Neurosurg. 2018 Dec;120:e637-e650. doi: 10.1016/j.wneu.2018.08.138. Epub 2018 Aug 29.

引用本文的文献

1
Short review/perspective: Critical early treatment of infections including meningitis and/or ventriculitis due to recurrent postoperative lumbar cerebrospinal fluid leaks, lumbar drains, or intracranial devices/implants.简短综述/观点:对因复发性术后腰椎脑脊液漏、腰椎引流管或颅内装置/植入物导致的包括脑膜炎和/或脑室炎在内的感染进行关键的早期治疗。
Surg Neurol Int. 2025 Jun 13;16:240. doi: 10.25259/SNI_535_2025. eCollection 2025.

本文引用的文献

1
M-CSF, IL-6, and TGF-β promote generation of a new subset of tissue repair macrophage for traumatic brain injury recovery.M-CSF、IL-6 和 TGF-β 促进了创伤性脑损伤恢复中新的组织修复巨噬细胞亚群的产生。
Sci Adv. 2021 Mar 12;7(11). doi: 10.1126/sciadv.abb6260. Print 2021 Mar.
2
A Systematic Review of the Effect of Delayed Appropriate Antibiotic Treatment on the Outcomes of Patients With Severe Bacterial Infections.延迟适当抗生素治疗对严重细菌感染患者结局影响的系统评价。
Chest. 2020 Sep;158(3):929-938. doi: 10.1016/j.chest.2020.03.087. Epub 2020 May 22.
3
Intrathecal Antibacterial and Antifungal Therapies.
鞘内抗菌和抗真菌治疗。
Clin Microbiol Rev. 2020 Apr 29;33(3). doi: 10.1128/CMR.00190-19. Print 2020 Jun 17.
4
Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017.成人医疗保健相关感染相关的抗微生物药物耐药病原体:2015-2017 年向国家医疗保健安全网络报告的数据摘要。
Infect Control Hosp Epidemiol. 2020 Jan;41(1):1-18. doi: 10.1017/ice.2019.296. Epub 2019 Nov 26.
5
Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical intracranial infection due to multidrug-resistant and extensively drug-resistant Gram-negative bacteria: A systematic review and meta-analysis.鞘内或脑室抗菌治疗神经外科术后颅内感染耐多药和广泛耐药革兰氏阴性菌:系统评价和荟萃分析。
Int J Antimicrob Agents. 2019 Nov;54(5):556-561. doi: 10.1016/j.ijantimicag.2019.08.002. Epub 2019 Aug 6.
6
Impact of pre-hospital antibiotic therapy on mortality in invasive meningococcal disease: a propensity score study.院前抗生素治疗对侵袭性脑膜炎球菌病患者死亡率的影响:一项倾向评分研究。
Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1671-1676. doi: 10.1007/s10096-019-03599-8. Epub 2019 May 28.
7
Current Practices of Intraventricular Antibiotic Therapy in the Treatment of Meningitis and Ventriculitis: Results from a Multicenter Retrospective Cohort Study.脑室抗生素治疗在脑膜炎和脑室炎治疗中的应用现状:一项多中心回顾性队列研究的结果。
Neurocrit Care. 2019 Jun;30(3):609-616. doi: 10.1007/s12028-018-0647-0.
8
Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: A review and update.脑室内注射抗生素治疗中枢神经系统感染:综述与更新
Clin Neurol Neurosurg. 2018 Jul;170:140-158. doi: 10.1016/j.clineuro.2018.05.007. Epub 2018 May 17.
9
The 21st-century challenge to neurocritical care: the rise of the superbug Acinetobacter baumannii. A meta-analysis of the role of intrathecal or intraventricular antimicrobial therapy in reduction of mortality.21 世纪神经危重症的挑战:超级细菌鲍曼不动杆菌的崛起。鞘内或脑室内抗菌治疗降低死亡率的作用的荟萃分析。
Neurosurg Focus. 2017 Nov;43(5):E8. doi: 10.3171/2017.8.FOCUS17443.
10
Intrathecal and intraventricular antibiotics for postoperative Gram-negative meningitis and ventriculitis.鞘内和脑室内注射抗生素用于术后革兰氏阴性菌脑膜炎和脑室炎。
Surg Neurol Int. 2017 Sep 26;8:226. doi: 10.4103/sni.sni_81_17. eCollection 2017.